Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02996916Phase 4Unknown
A Phase 4 trial of olmesartan in essential hypertension, sponsored by Kurume University. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02996916.